Investor Presentation

Fabtech Technologies Limited's investor presentation for FY26 highlights a strong financial performance, with revenue from operations growing 25.7% YoY to ₹410.77 Cr and operational profit up 17.0% YoY to ₹36.60 Cr. The company reported a consolidated order book of over ₹900 Cr as of March 31, 2026, providing significant revenue visibility. Strategic wins include new projects in Animal Health, KSA vaccine and advanced pharma facilities, and large-scale African pharma infrastructure. Fabtech is expanding its global footprint and diversifying into high-growth sectors, demonstrating resilient performance despite geopolitical challenges and supply chain disruptions.